RSS
ATOM
JSON
Sort by:
Date tagged
Date published
-
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
https://api.zotero.org/groups/2494380/items/TLAQPAWG?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020
-
On the recommendation of the data safety and monitoring board, @REMAP_CAP is declaring efficacy of #tocilizumab with an OR of 1.87 for benefit on a combination of survival and length of time patients received organ support in ICU, compared with standard care [...]
https://api.zotero.org/groups/2494380/items/3347JHRP?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020